Live Feeds
● TRACKER Updated 3d ago · 53 sources tracked

Women turn to testosterone for low sex drive as doctors confront treatment ‘experimentation’

Postmenopausal women are increasingly using off-label testosterone to treat menopause symptoms and low libido, despite new research linking the therapy to higher rates of cardiovascular dangers such as heart attack, stroke, and heart failure. While social media platforms circulate claims promoting testosterone for menopause, medical experts warn that the treatment lacks sufficient evidence of benefit and falls decades behind proper clinical evaluation. Most current prescriptions bypass the only approved indication for hypoactive sexual desire disorder, raising concerns among physicians about widespread treatment experimentation.

🎙️

Listen to Live Briefing

Real-time synthesized voice briefing · Live Feeds Desk

⏱ ~3 min
Speed:
RSS Source map (53)
⚡ Key Developments & Real-Time Context
Text size:
  • ✓ Off-label testosterone prescriptions for women have surged, with most not used for the approved indication of hypoactive sexual desire disorder.
  • ✓ Testosterone therapy in postmenopausal women is linked to higher cardiovascular risk, including heart attack, stroke, and heart failure.
🛡️ Source Corroboration: 53 independent reporting domains (100% confidence) ⏱ Read time: ~2 min

What changed

New research presented at the October 2026 annual meeting of The Menopause Society links testosterone therapy in postmenopausal women to a sharp rise in heart attacks, strokes, and heart failure.

Live updates

  1. Testosterone Therapy Tied to Heart Risks for Women

    Postmenopausal women are increasingly using off-label testosterone to treat menopause symptoms and low libido, despite new research linking the therapy to higher rates of cardiovascular dangers such as heart attack, stroke, and heart failure. While social media platforms circulate claims promoting testosterone for menopause, medical experts warn that the treatment lacks sufficient evidence of benefit and falls decades behind proper clinical evaluation. Most current prescriptions bypass the only approved indication for hypoactive sexual desire disorder, raising concerns among physicians about widespread treatment experimentation.

    Why it matters

    Off-label testosterone use has surged as women seek relief from energy loss, mood changes, and sexual health challenges during menopause. Physicians question whether mild sexual improvements outweigh severe cardiovascular consequences. Medical literature and recent studies highlight a persistent gap in clinical research regarding appropriate dosing and long-term safety for female patients.

    What is confirmed

    • Off-label testosterone prescriptions for women have surged, with most not used for the approved indication of hypoactive sexual desire disorder.
    • Testosterone therapy in postmenopausal women is linked to higher cardiovascular risk, including heart attack, stroke, and heart failure.

    Still unconfirmed

    • Social media claims suggest testosterone helps with menopause symptoms, though a new study finds insufficient evidence.
    • Some women resort to posing as men to obtain testosterone gel due to difficulties in securing off-label prescriptions.

    What to watch next

    • Further clinical trial results evaluating the true efficacy and safety dosing of testosterone for women.
    • Regulatory or medical society responses to the surge in off-label testosterone prescriptions.
    Sources used for this update (6)
    1. www.endocrinologyadvisor.com — Hormone Replacement Therapy for Menopause: Off-Label Risks ...
    2. pacifictribune.com — Testosterone for menopause: does it work? - pacifictribune.com
    3. thehormoneproject.substack.com — The Forgotten Female Hormone - Shawn Tassone, MD, PhD
    4. www.foxnews.com — Women's sex drive treatment linked to higher rates of heart ...
    5. www.aol.com — Can testosterone improve menopause symptoms? Here's ... - AOL
    6. libertyonenews.com — Testosterone Therapy for Postmenopausal Women Tied to Sharp ...
    confidence 100%
  2. Women seek testosterone for low sex drive, sparking safety concerns

    Postmenopausal women are increasingly turning to off-label testosterone therapy to treat low libido, menopause symptoms, energy loss, and mood changes, despite limited long-term safety data and links to cardiovascular risks. Doctors warn of treatment experimentation, with some women posing as men to obtain testosterone gel. Users report mild sexual improvements, but physicians question whether benefits outweigh cardiovascular dangers.

    Why it matters

    The trend raises concerns about patient safety and the role of private prescribing in the UK's National Health Service. Medical experts are urging caution due to the potential risks associated with testosterone therapy. The issue highlights the challenges of treating menopausal symptoms and the need for more research on effective and safe treatments.

    What is confirmed

    • Postmenopausal women are seeking off-label testosterone therapy to treat low libido, menopause symptoms, energy loss, and mood changes.
    • Testosterone therapy is linked to cardiovascular risks, including heart attack and stroke.
    • The rapid expansion of private testosterone prescribing risks overtreatment and more strain on the NHS.
    • Researchers found an association between off-label testosterone therapy and incident cardiovascular disease in postmenopausal women.

    Still unconfirmed

    • Some women are posing as men to obtain testosterone gel.

    What to watch next

    • Further research on the long-term safety and efficacy of testosterone therapy in postmenopausal women
    • UK regulatory decisions on private testosterone prescribing and NHS coverage
    • Publication of more studies on cardiovascular risks and benefits of testosterone therapy
    Sources used for this update (3)
    1. medicalupdateonline.com — Rise in private testosterone prescribing risks overtreatment ...
    2. www.clinicaladvisor.com — Cardiovascular Disease Risk Rises Significantly With ...
    3. www.sciencealert.com — Testosterone May Have an Unexpected Benefit For Women's Bones ...
    confidence 90%
  3. Women Seeking Testosterone Face Heart Risks and Treatment Concerns

    Postmenopausal women increasingly seek off-label testosterone therapy to treat low libido, menopause symptoms, energy loss, and mood changes, despite limited long-term safety data. Recent findings link the treatment to cardiovascular risks, including heart attack and stroke. A recent study specifically points to a significantly higher rate of heart and stroke events among postmenopausal women using testosterone. Medical experts warn that patients are engaging in treatment experimentation, with some women even posing as men to obtain testosterone gel. While users anecdotally report mild sexual improvements alongside energy and mood gains, physicians question whether these benefits outweigh the substantial cardiovascular dangers.

    Why it matters

    The off-label use of testosterone among women has grown as patients search for relief from aging and menopause symptoms. However, medical guidelines do not routinely recommend the therapy due to a lack of robust long-term safety data. The emergence of severe cardiovascular signals forces doctors to confront widespread treatment experimentation and the potential overprescription of testosterone for nonspecific health complaints.

    What is confirmed

    • Postmenopausal women using testosterone therapy face a risk of incident cardiovascular disease, including heart attack and stroke.
    • Long-term safety data for testosterone therapy in women remain limited, meaning the treatment is not routinely recommended.

    Still unconfirmed

    • Women have posed as men to acquire testosterone gel in order to treat menopause symptoms.
    • A retrospective survey shows that women on testosterone more frequently report gains in energy and mood than in sexual desire.
    • A new study links testosterone therapy in postmenopausal women to an eightfold higher rate of heart and stroke events.

    What to watch next

    • Further clinical research quantifying the exact cardiovascular risks of testosterone therapy in women
    • Updates to medical guidelines regarding off-label hormone prescriptions for menopause symptoms
    Sources used for this update (3)
    1. geneticliteracyproject.org — Testosterone’s growing appeal to women: It anecdotally mildly improves sex life, but are there any other potential benefits—or....
    2. www.medscape.com — Women on Testosterone Report Energy, Mood Gains - Medscape
    3. drjessemorse.substack.com — Testosterone for Women Just Got a Heart Warning. Here’s How ...
    confidence 100%
  4. New research links postmenopausal testosterone therapy to heart disease

    Postmenopausal women using testosterone therapy for low libido face a higher risk of incident cardiovascular disease, including heart attack and stroke. Findings presented at the 2026 Annual Meeting of The Menopause Society indicate that long-term safety data remain limited, meaning the treatment is not routinely recommended. While some women continue to seek off-label prescriptions for libido and menopause symptoms, medical experts question if the benefits outweigh these cardiovascular risks. This development adds to existing concerns regarding the overprescription of testosterone for nonspecific symptoms.

    Why it matters

    Testosterone is typically associated with male physiology but is prescribed off-label to women for mood swings, brain fog, and sex drive. A lack of long-term safety data has already caused some pharmacies to delay prescriptions. The current debate centers on whether private prescriptions risk patient health for limited gains.

    What is confirmed

    • Testosterone therapy is not routinely recommended for postmenopausal women due to limited long-term safety data.
    • A study presented at the 2026 Annual Meeting of The Menopause Society links testosterone therapy in postmenopausal women with a higher risk of incident cardiovascular disease.

    Still unconfirmed

    • The telehealth company Hims plans to offer testosterone replacement therapy as its first foray into prescribing controlled substances.

    What to watch next

    • Publication of the full peer-reviewed data from the 2026 Annual Meeting of The Menopause Society.
    • Official guidance updates from medical boards regarding off-label testosterone prescriptions for women.
    Sources used for this update (5)
    1. www.wired.com — Telehealth Giant Hims Wants to Test Every Dude for Low Testosterone
    2. medicalxpress.com — Testosterone therapy may increase risk of cardiovascular ...
    3. www.medicinenet.com — Testosterone Therapy Linked To Heart Attack, Stroke Among ...
    4. myendoconsult.com — Testosterone Pellets for Women – My Endo Consult
    5. www.everydayhealth.com — Testosterone Therapy May Raise Heart Disease Risk in Women
    confidence 90%
  5. Menopausal women increase off-label testosterone use despite limited evidence

    Women are increasingly using off-label testosterone to treat menopause symptoms including low sex drive, mood swings, and brain fog. While popularity is rising, medical experts warn that evidence supporting this approach remains limited. This trend has led to a rise in prescription denials and pharmacy delays. Some specialists warn that expanding private prescriptions risks overtreating individuals with nonspecific symptoms or borderline test results, making the balance of long-term risk and benefit less certain.

    Why it matters

    The U.S. has no approved testosterone products specifically for women. Patients often seek these treatments after medical practitioners dismiss sexual health concerns or fail to address the complex causes of low libido.

    What is confirmed

    • Off-label testosterone prescriptions for menopausal women are increasing.
    • Experts state there is limited evidence to support using testosterone for menopause symptoms.

    Still unconfirmed

    • Private testosterone prescribing risks extending treatment to people with borderline test results and nonspecific symptoms.

    What to watch next

    • Clinical trials providing evidence for testosterone efficacy in treating menopause symptoms
    • FDA approval or guidance on testosterone products specifically for women
    Sources used for this update (6)
    1. www.livescience.com — Testosterone for menopause: The treatment is rising in ...
    2. theweek.com — The growing use of testosterone to treat menopause
    3. developmentstoday.com — Testosterone for Menopause: Use Rises, Evidence Lags
    4. omaha.com — Testosterone scripts for women rise with denials, delays
    5. medicalxpress.com — Rise in private testosterone prescribing risks overtreatment ...
    6. nypost.com — What is TRT? Experts weigh benefits, side effects and safety
    confidence 90%
  6. Women seek testosterone for menopause symptoms

    Perimenopausal and menopausal women increasingly use off-label testosterone therapy to address low sex drive and symptoms. This trend persists even though there are no U.S. approved testosterone products specifically for women. Patients now face unexpected prescription denials and delays at pharmacies while attempting to secure treatments. Medical practitioners sometimes dismiss women sexual health problems, leaving patients to navigate hormone factors, stress, pain, medicines, and relationship elements that contribute to low libido.

    Why it matters

    Women naturally produce testosterone, but the evidence supporting its use for female hormone therapy varies significantly in strength depending on the clinical context. In Europe, prescribing practices differ from the United States, where the lack of approved female-specific options forces reliance on off-label regimens. Patients seeking relief for postmenopausal distress encounter barriers within the pharmacy system.

    What is confirmed

    • An increasing number of women in perimenopause and menopause are turning to testosterone as off-label therapy to manage their symptoms.
    • Women who use testosterone therapy to manage menopause symptoms are experiencing unexpected prescription delays and denials at pharmacies.
    • Women produce testosterone.

    Still unconfirmed

    • Testosterone therapy may be helpful for women in postmenopause whose lack of sex drive is causing distress.

    What to watch next

    • Changes in U.S. drug approval status for female-specific testosterone products
    • Shifts in pharmacy fulfillment policies for off-label hormone prescriptions
    Sources used for this update (7)
    1. www.medscape.com — Is Testosterone Appropriate for Women in Menopause? - Medscape
    2. agesync.com — Testosterone in Women: What the Evidence Actually Supports
    3. www.yahoo.com — Women turning to testosterone therapy running into ... - Yahoo
    4. www.youtube.com — Women make testosterone too—so why is prescribing it still so ...
    5. www.healthline.com — Testosterone for Women to Improve Sexual Drive: A Guide
    6. www.cnn.com — Why doctors sometimes ignore women’s sexual health | CNN
    7. www.acibademhealthpoint.com — Low Libido in Women: Possible Causes, Hormone Factors, and ...
    confidence 90%
  7. Women turn to testosterone for low sex drive amid treatment scarcity

    Women are using testosterone to treat menopause symptoms and low libido, despite limited female-specific products and inconclusive scientific evidence. The FDA recently held a workshop to explore benefits for energy, overall health, and sexual desire. Some women have reportedly posed as men to obtain testosterone gel due to limited availability.

    Why it matters

    The issue matters as it highlights a gap in menopause care, with women seeking alternative treatments due to limited options. The FDA's workshop and Congress's review of menopause care indicate growing attention to the issue. The military's policy requiring alternative drugs for service members who want children adds to the complexity.

    What is confirmed

    • The FDA held a workshop in September 2026 to explore benefits for energy, overall health, and sexual desire, urging sponsors to conduct more rigorous studies.
    • Women are increasingly using testosterone to treat menopause symptoms and low libido, despite a scarcity of female-specific products and patchy scientific evidence.
    • The military has implemented a policy requiring alternative drugs for service members who want children.

    Still unconfirmed

    • Some women have reportedly posed as men to obtain testosterone gel due to limited availability.

    What to watch next

    • FDA approval of female-specific testosterone products
    • Congress's review of menopause care
    • Results of further studies on testosterone benefits for women
    Sources used for this update (2)
    1. www.biography.com — 51 Famous Women in History Who Have Changed the World
    2. www.unwomen.org — Welcome | UN Women – Headquarters
    confidence 90%
  8. FDA Urges New Studies as Women Seek Testosterone for Menopause

    Women are increasingly using testosterone to treat menopause symptoms and low libido, despite a scarcity of female-specific products and patchy scientific evidence. The FDA held a workshop in September 2026 to explore benefits for energy, overall health, and sexual desire, urging sponsors to conduct more rigorous studies. Some women have reportedly posed as men to obtain testosterone gel due to limited availability. While federal regulators and Congress are now reviewing menopause care, the military has implemented a policy requiring alternative drugs for service members who want children.

    Why it matters

    Testosterone is primarily associated with male development but is biologically present in women. Because most available products were designed for men, medical professionals warn of treatment experimentation. Federal authorities are now following policy leads from states like California to standardize hormone access.

    What is confirmed

    • The FDA held a workshop in September 2026 regarding testosterone use for menopausal women.
    • Female-specific testosterone products remain scarce.
    • The FDA has urged sponsors to conduct more studies on testosterone use in women.

    Still unconfirmed

    • Some women have posed as men to acquire testosterone gel to treat menopause symptoms.
    • Military policy requires an alternative drug for service members seeking testosterone who want children.
    • Federal government menopause care policies are following the lead of California.

    What to watch next

    • Results of new FDA-sponsored clinical trials for female-specific testosterone
    • Legislative action from Congress following menopause care hearings
    • Updated military guidelines on hormone therapy and fertility
    Sources used for this update (15)
    1. www.military.com — The Fertility Question Tied to the Military's New Testosterone Policy
    2. en.wikipedia.org — Woman - Wikipedia
    3. simple.wikipedia.org — Woman - Simple English Wikipedia, the free encyclopedia
    4. en.wikipedia.org — Female - Wikipedia
    5. www.women.com — Women | News, Celebrity, Lifestyle, and Expert Opinions
    6. www.gettyimages.com — 28,394,802 Women Images and Stock Photos - Getty Images
    7. www.medicalnewstoday.com — Female anatomy: Body parts, their functions, and diagram
    8. uk.news.yahoo.com — Women are turning to testosterone, but what does the science ...
    9. insights.citeline.com — Testosterone Use In Women: US FDA Urges Sponsors To Try Again ...
    10. jaycampbell.com — TRT for Women: Benefits of Testosterone for Females
    11. scienceinsights.org — Human Sexuality: How Biology and Psychology Shape Desire
    12. www.aol.com — The benefits of testosterone for women, according to 1,220 ...
    confidence 85%
  9. Surging Testosterone Prescriptions for Women Face FDA and Senate Scrutiny

    Women are increasingly seeking testosterone prescriptions to treat low libido, prompting a surge in prescriptions alongside insurance delays and denials. However, replacing the hormone as a supplement presents complex challenges, as the products are often prescribed off-label and were never originally designed for women. Medical professionals are now confronting what some describe as treatment experimentation. In response to these growing trends, federal regulators and lawmakers are taking direct notice of the landscape, with Congress holding its first hearing on menopause care and the FDA meeting to evaluate testosterone use for women.

    Why it matters

    Testosterone plays a major role in a woman's sex drive, but using it as a supplement requires navigating off-label usage and potential treatment barriers. These therapies have quickly become a major topic of discussion within healthcare and regulatory circles as more patients request the hormone. The recent alignment of congressional hearings and federal regulatory meetings highlights a growing urgency to address safety, efficacy, and clinical standards.

    What is confirmed

    • Testosterone plays a major role in a woman's sex drive.
    • Congress held its first hearing on menopause care.
    • The FDA met to examine the use of testosterone for women.

    Still unconfirmed

    • Replacing fizzled sex drive with testosterone supplementation is not as simple as it sounds.
    • Testosterone has become one of the hottest topics regarding off-label prescriptions for menopause.
    • Women face insurance denials and delays when seeking testosterone prescriptions.

    What to watch next

    • Any formal policy or regulatory guidance issued by the FDA following its meeting on testosterone for women
    • Further legislative actions or recommendations emerging from the Senate menopause hearing
    Sources used for this update (4)
    1. health.yahoo.com — Testosterone and Low Libido in Women - health.yahoo.com
    2. creators.yahoo.com — Testosterone prescriptions surging for women—even with more ...
    3. currently.att.yahoo.com — Your doctor prescribed testosterone for menopause. So why won ...
    4. procompounding.com — Senate Menopause Hearing: Clinic Takeaways | ProCompounding
    confidence 90%
  10. FDA Reviews Testosterone Use for Menopausal Women Amid Rising Demand

    Women are increasingly seeking testosterone prescriptions to treat low sex drive, leading to a rise in prescriptions alongside more frequent insurance denials and delays. The FDA is now examining the use of these prescriptions for menopause and has scheduled a public meeting to address the issue. Medical professionals are currently grappling with what some describe as treatment experimentation as more patients request the hormone.

    Why it matters

    Testosterone is not traditionally prescribed for women, creating a gap between patient demand and standardized medical guidelines. This tension has led to inconsistent prescribing patterns and challenges with insurance coverage.

    What is confirmed

    • The FDA is examining the use of testosterone prescriptions for menopause.
    • The FDA is holding a public meeting regarding testosterone use in menopausal women.
    • Prescriptions for testosterone among women are increasing.

    Still unconfirmed

    • Insurance denials and delays for testosterone prescriptions are rising.

    What to watch next

    • Outcomes and recommendations from the FDA public meeting
    • Updated FDA guidelines on testosterone for menopausal symptoms
    Sources used for this update (5)
    1. Fox News — Women turn to testosterone for low sex drive as doctors confront treatment ‘experimentation’
    2. ABC News - Breaking News, Latest News and Videos — FDA examines use of testosterone prescriptions for menopause
    3. CNN — Testosterone scripts for women rise, along with denials and delays
    4. Yahoo — Why more women are asking about testosterone — and having trouble getting it
    5. contemporaryobgyn.net — FDA holding public meeting on testosterone use in menopausal women
    confidence 90%
📊

Community Sentiment: How do you assess this situation?

Voice your perspective · Real-time aggregated sentiment from the Live Feeds community